46 A Phase 2a Randomized Placebo-Controlled Double-Blind Multi-Center Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011 in Patients With Moderately Active Ulcerative Colitis
Severine Vermeire, Paul J. Rutgeerts, Geert R. D'Haens, Martine De Vos, Brian Bressler, Annegret Van der Aa, Bernard Coulie, Cindy J. Wong, Brian G. FeaganVolume:
138
Year:
2010
Language:
english
DOI:
10.1016/s0016-5085(10)60041-8
File:
PDF, 47 KB
english, 2010